This month's top tech news stories
Leeds Beckett University
New biomedical science lab
A new biomedical science lab, which will be used to carry out research into diseases including cancer and diabetes, as well as looking at antimicrobial resistance, has been officially opened at Leeds Beckett University. The lab, which is based at the School of Health, City Campus houses specialist equipment that will enable undergraduate and postgraduate students to engage with cutting-edge research. This includes the latest technologies, such as imaging flow cytometry and real-time PCR.
Capitainer
Protocols for biomarkers
The Swedish medtech company Capitainer AB announced a research collaboration with AstraZeneca. AstraZeneca will use a novel device from Capitainer to develop protocols for biomarkers relevant to AstraZeneca’s clinical drug programmes. The collaboration aims to develop protocols for biomarkers relevant to AstraZeneca’s clinical drug programmes based on Capitainer’s novel self-sampling product delivering cell-free blood. This allows new patient-centric sampling solutions.
Promega
Wastewater testing
Wastewater testing labs can now scale up their infectious disease surveillance using two reliable technologies in a single kit. The new system released by Promega Corporation pairs the company’s Maxwell HT chemistry with Ceres Nanosciences’ Nanotrap particles, an established technology for capturing and concentrating low-abundance analytes, such as viral particles. Together, these technologies empower labs to purify pathogen nucleic acids from wastewater samples in high-throughput workflows. “Ceres has a technology that enables concentration of microbes from wastewater that is unique to the market,” said Brandon Krueger, Promega Field Support Scientist.
Image credit | Leeds-Beckett-University | Capitainer | Promega-Corporation
